RxDoctor Payments Data

Connor Rezzonico

Psychiatric/Mental Health · Coeur D Alene, IDNPI 1063184968

Payments from drug & device makers

$1,532in general payments, 2019–2025

Across 77 payments — averaging $19.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$434
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$273
  • Neurocrine Biosciences, Inc.$136
  • Johnson & Johnson$118
  • Lundbeck LLC$115
  • Axsome Therapeutics, Inc.$113
  • plus $343 from 6 others

What the payments were for

  • Food & beverage$1,38690%
  • Education$14610%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,532 in reported general payments places this provider in the 70th percentile of 221 psychiatric/mental health providers in Idaho.

See all psychiatric/mental health providers in Idaho

Medicare billing

Part B allowed, 2024
$803
Medicare patients
42
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate27$80,640
VraylarCariprazine Hcl23$30,817
CaplytaLumateperone Tosylate14$25,446
TrintellixVortioxetine Hydrobromide11$7,955
Lurasidone Hcl51$4,663
Atomoxetine Hcl16$4,287
Aripiprazole37$3,274
Paliperidone ErPaliperidone21$2,705
Lisdexamfetamine Dimesylate15$2,599
Quetiapine Fumarate ErQuetiapine Fumarate42$2,594
Methylphenidate ErMethylphenidate Hcl15$2,526
Olanzapine52$1,990
Trazodone Hcl87$1,720
Buspirone Hcl92$1,616
Hydroxyzine Hcl54$1,364

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$118$80,64027 claims
AbbVieVraylar$55$30,81723 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$273$25,44614 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$19$7,95511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 221 psychiatric/mental health providers in Idaho.

Other psychiatric/mental health in Coeur D Alene

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →